Back to results
US 10,646,459 B2Granted
Sphingosine pathway modulating compounds for the treatment of cancers
AssigneeEnzo Biochem, Inc.
InventorsElazar Rabbani, James J. Donegan
Life of this patent
Estimating the term…
Abstract
The invention provides methods and compositions for treating cancers and myeloproliferative disorders using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod.
Claims4
A method for treating Acute lymphoblastic leukemia (ALL) in a mammalian subject, comprising the step of:
- administering to a mammalian subject in need of treatment for Acute lymphoblastic leukemia (ALL) an effective amount of ozanimod or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.